Canada sees results of price-reduction policy

Canadian pricing policies have “markedly reduced the price of generic drugs, reining in the growth in sales”, according to the latest study on generic drug pricing in Canada by the country’s Patented Medicine Prices Review Board (PMPRB). However, the report – based on Iqvia data and national prescribing information to the end of 2016 – points out, “international generic prices are still significantly lower”.